Trademarkia Logo

Canada

C$
FILSPARI
REGISTERED

on 6 Sept 2023

Last Applicant/ Owned by

TRAVERE THERAPEUTICS INC.

3611 Valley Centre DriveSuite 300San Diego CA 92130

US

Serial Number

2164219 filed on 3rd Jan 2022

Registration Number

TMA1197207 registered on 6th Sept 2023

Registration expiry Date

8th Jul 2031

FILSPARI

Trademark usage description

pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis ( Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome.


Classification kind code

11

Mark Details


Serial Number

2164219

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 14th Jun 2023
Advertised
Submitted for opposition 26
on 18th May 2023
Approved
Submitted for opposition 27
on 18th May 2023
Approval Notice Sent
Submitted for opposition 22
on 12th May 2023
Search Recorded
Submitted for opposition 256
on 5th Dec 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 3rd Feb 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 2th Feb 2022
Created
Submitted for opposition 31
on 2th Feb 2022
Formalized
Submitted for opposition 30
on 3rd Jan 2022
Filed
Submitted for opposition 228
on 8th Jul 2021
International Registration